Tonix Pharmaceuticals Holding Corp.
TNXP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 64.7% | -17.7% | -5.9% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 58.4% | -63.8% | 61.2% | 54.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -958.9% | -1,392% | -672.5% | -837% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -972.9% | -1,415% | -692.8% | -856.2% |
| EPS Diluted | -3.59 | -3.86 | -2.84 | -9.77 |
| % Growth | 7% | -35.9% | 70.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |